Therapeutic Asset Ratings
1,583 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
PBR-06
MSA - Multiple System Atrophy
Brigham and Women's Hospital
Early P1
CC
(43)
pep2dia
PCOS
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Early P1
CC
(43)
PITAVASTATIN
Glioblastoma Multiforme, Adult
C.Dirven
Early P1
CC
(43)
Rag-17
Gene Mutation
Beijing Tiantan Hospital
Early P1
CC
(43)
Recombinant Human EGF-rP64K
Chronic Obstructive Pulmonary Disease
Roswell Park Cancer Institute
Early P1
CC
(43)
Recombinant Human EGF-rP64K
Pneumonia
Roswell Park Cancer Institute
Early P1
CC
(43)
Sodium Lactate
GLUT1 Deficiency Syndrome
Radboud University Medical Center
Early P1
CC
(43)
Sodium Lactate
GLUT1DS1
Radboud University Medical Center
Early P1
CC
(43)
Sodium Lactate
GLUT1DS2
Radboud University Medical Center
Early P1
CC
(43)
Sodium Lactate
Lactic Acid Blood Increased
Radboud University Medical Center
Early P1
CC
(43)
Sra-333
Ensure the Legality and Compliance of the Testing Process
Changchun University of Chinese Medicine
Early P1
CC
(43)
TECHNETIUM TC 99M PYROPHOSPHATE
Aortic Stenosis
Mayo Clinic
Early P1
CC
(43)
TECHNETIUM TC 99M PYROPHOSPHATE
Transthyretin Amyloid Cardiomyopathy
Mayo Clinic
Early P1
CC
(43)
TECHNETIUM TC 99M PYROPHOSPHATE
Transthyretin Amyloidosis
Mayo Clinic
Early P1
CC
(43)
Topamax
Obesity, Childhood
University of Minnesota
Early P1
CC
(43)
VITAMIN D
Immunology
Suzhou Municipal Hospital of Anhui Province
Early P1
CC
(43)
VITAMIN D
Neurology
Suzhou Municipal Hospital of Anhui Province
Early P1
CC
(43)
5-azacytidine
Breast Carcinoma
City of Hope Medical Center
Early P1
CC
(41)
CANNABIVAROL, .DELTA.9-TETRAHYDRO-
Morbid Obesity
Medical Life Care Planners, LLC
Early P1
CC
(41)
carbidopa
Healthy Volunteers
University of Minnesota
Early P1
CC
(41)
cd-801
Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Early P1
CC
(41)
Cd-Ga-102
Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Early P1
CC
(41)
Cediranib
Gastrointestinal Cancer
City of Hope Medical Center
Early P1
CC
(41)
Copper Cu-64-Dota-Alendronate
Breast Carcinoma
City of Hope Medical Center
Early P1
CC
(41)
Evolocumab
Malignant Glioma
Duke University
Early P1
CC
(41)
Showing 51 to 75 of 1,583 assets
Previous
Page 3 of 64
Next
